Dabrafenib 17088-0212
Product NDC
17088-0212- Manufacturer
- Novartis Pharma Stein Ag
- Dosage Form
- Tablet, For Suspension
- Product Type
- Human Prescription Drug
- Marketing Start
- March 16, 2023
- Listing Expires
- December 31, 2026
Need to source Dabrafenib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dabrafenib Mesylate | 10 mg/1 |
Packaging Options(1)
25000 TABLET, FOR SUSPENSION in 1 DRUM (17088-0212-1)